Viking disease is the common nickname for Dupuytren’s contracture, a condition where thick cords of tissue form in the palm of your hand and gradually pull one or more fingers into a bent position. It earned the Viking nickname because it’s most common in people of Northern European descent, though recent genetic research has challenged whether it truly traces back to Norse populations. The condition is painless for most people but progressive, and in advanced cases it can make it difficult to grip objects, shake hands, or lay your palm flat.
What Happens Inside the Hand
A sheet of tough connective tissue called the palmar fascia sits just beneath the skin of your palm. In a healthy hand, this tissue fans out from the wrist and splits into bands running toward each finger, helping you grip. In Dupuytren’s contracture, specialized cells called myofibroblasts multiply within this tissue and begin depositing excess collagen. Over time, these cells align along tension lines and form firm nodules you can feel under the skin.
The disease progresses through distinct phases. First, nodules appear in the palm, usually near the base of the ring or little finger. Then the nodules connect and form a thick cord that runs from the palm into the affected finger. Eventually, the myofibroblasts disappear and leave behind dense, acellular bands of collagen that tighten like a drawstring, pulling the finger toward the palm. Once this contracture sets in, you can’t straighten the finger on your own.
Why It’s Called Viking Disease
The nickname comes from a long-held belief that the condition originated with Viking populations and spread across Northern Europe and into the British Isles along Norse migration routes. Dupuytren’s contracture is indeed far more common in Scandinavian countries, the UK, and populations of Northern European ancestry. That geographic pattern made the Viking origin story compelling for decades.
However, a University of Bristol study using genetic analysis found no evidence to support it. Researchers compared genetic markers between populations in Orkney (with strong Norse ancestry), Wales (ancient British ancestry), and Southeast England (Anglo-Saxon ancestry). Using a technique called chromosome painting, they looked at whether the genetic variants associated with Dupuytren’s were concentrated in Norse-descended populations. They weren’t. The disease-associated variants showed no geographic clustering that would point to a Viking origin. The nickname has stuck anyway.
Risk Factors
The strongest risk factor is family history. If a close relative has Dupuytren’s, your chances increase substantially. The condition is also far more common in men than women and typically appears after age 50, though aggressive forms can show up earlier.
Both alcohol and tobacco use raise the risk in a dose-dependent way, meaning the more you drink or smoke, the higher the odds. A prospective study found that risk increased steadily with higher levels of either substance, even after adjusting for age, sex, education, and diabetes. Interestingly, heavy smoking combined with heavy drinking didn’t multiply the risk beyond what each contributed individually. Diabetes is also associated with the condition, though studies have not found that diabetes worsens the severity of contracture once it develops.
How It Feels and Progresses
The earliest sign is usually a small, firm lump in the palm near the base of the ring finger or little finger. Some people notice skin puckering or dimpling in the same area. At this stage there’s little or no pain and no restriction in movement. Many people live with early-stage Dupuytren’s for years without it progressing further.
When it does progress, a cord develops beneath the skin and the finger begins to curl inward. Doctors classify severity by how far the finger has contracted:
- Stage 0: Nodules or bands present, but no contracture
- Stage I: Total contracture up to 45 degrees
- Stage II: Contracture between 45 and 90 degrees
- Stage III: Contracture between 90 and 135 degrees
- Stage IV: Contracture beyond 135 degrees, with the finger nearly touching the palm
Progression is unpredictable. Some people stay at Stage 0 or I for decades. Others advance through the stages over just a few years, particularly those who develop the condition before age 50 or who have a strong family history.
The Tabletop Test
There’s a simple self-check you can do at home. Place your palm flat on a table and try to press all your fingers completely flat against the surface. If you can’t flatten one or more fingers, particularly the ring or little finger, that’s a positive result and a sign you may benefit from evaluation. This is known as the Hueston tabletop test, and it’s the same screening method used in clinical settings.
Related Conditions
Dupuytren’s contracture belongs to a family of fibromatosis conditions, all involving abnormal connective tissue buildup in different parts of the body. Some people with Dupuytren’s also develop Ledderhose syndrome, which causes similar nodules on the soles of the feet. Others develop Peyronie’s disease, a buildup of fibrous tissue in the penis that causes curvature. Thickened pads over the finger knuckles, called Garrod’s pads, are another related condition. Having one of these conditions increases the likelihood of developing the others, suggesting a shared underlying tendency toward excessive collagen production.
Nonsurgical Treatment Options
Treatment typically isn’t recommended until the contracture starts interfering with hand function, usually around Stage I or II. For earlier stages, monitoring is the standard approach.
Two minimally invasive options are commonly used. Needle aponeurotomy (also called needle fasciotomy) involves inserting a needle through the skin to puncture and break apart the cord. It’s done in an office setting, requires no incision, and recovery takes days rather than weeks. The second option is an enzyme injection that dissolves the collagen in the cord, allowing the finger to be straightened manually the next day.
A five-year randomized trial published in the Journal of Hand Surgery compared these two approaches head to head. Both produced similar improvements, with a median gain of about 35 to 36 degrees of extension at the main knuckle joint. At five years, roughly half of patients in each group still maintained good correction without needing a second procedure. Recurrence was common in both groups: 56% for the enzyme injection and 45% for needle fasciotomy. These numbers highlight an important reality of Dupuytren’s. No treatment cures the underlying disease, so repeat procedures are often part of the long-term picture.
Surgical Treatment
For more advanced contractures or cases that have recurred after less invasive treatment, surgery becomes the better option. The standard procedure is a partial fasciectomy, where the surgeon removes the diseased tissue through an incision in the palm. Recovery takes several weeks and typically involves hand therapy to regain full motion and prevent scarring.
A more extensive option is dermofasciectomy, where the surgeon removes both the diseased tissue and the overlying skin, then replaces the skin with a graft taken from elsewhere on the body (often the inner arm or groin). A study of 100 patients found that while the overall recurrence rate after surgery was 46.5%, skin replacement following fasciectomy prevented nearly all recurrence of the diseased tissue in the grafted area. The skin graft did not compromise hand function, sensibility, or time to return to work, making it a particularly strong option for younger patients or those with aggressive, recurrent disease.
Living With Dupuytren’s Long Term
Dupuytren’s contracture is a chronic condition. Even after successful treatment, the underlying tendency to produce excess collagen remains. Recurrence rates across all treatment types range from roughly 45% to over 50% within five years. This doesn’t mean treatment isn’t worthwhile. Each intervention can restore years of improved hand function, and many people cycle through minimally invasive procedures as needed rather than progressing to surgery.
If you’re in the early stages with just a nodule and no contracture, there’s a good chance it will progress slowly or not at all. Keeping track of whether you can still pass the tabletop test is a practical way to monitor changes over time without frequent medical visits.